The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2.

Abstract

Castration-resistant prostate cancer (CRPC) is an aggressive lethal form of prostate cancer (PCa). Atraric acid (AA) not only inhibits the wild-type androgen receptor (AR) but also those AR mutants that confer therapy resistance to other clinically used AR antagonists, indicating a different mode of AR antagonism. AA induces cellular senescence and inhibits CRPC tumour growth in in vivo xenograft mouse model associated with reduced neo-angiogenesis suggesting the repression of intratumoural neo-angiogenesis by AA. In line with this, the secretome of CRPC cells mediates neo-angiogenesis in an androgen-dependent manner, which is counteracted by AA. This was confirmed by two in vitro models using primary human endothelial cells. Transcriptome sequencing revealed upregulated angiogenic pathways by androgen, being however VEGF-independent, and pointing to the pro-angiogenic factor angiopoietin 2 (ANGPT2) as a key driver of neo-angiogenesis induced by androgens and repressed by AA. In agreement with this, AA treatment of native patient-derived PCa tumour samples ex vivo inhibits ANGPT2 expression. Mechanistically, in addition to AA, immune-depletion of ANGPT2 from secretome or blocking ANGPT2-receptors inhibits androgen-induced angiogenesis. Taken together, we reveal a VEGF-independent ANGPT2-mediated angiogenic pathway that is inhibited by AA leading to repression of androgen-regulated neo-angiogenesis.

• Authors: Marzieh Ehsani, Sophie Bartsch, Seyed Mohammad Mahdi Rasa, Jessica Dittmann, Thanakorn Pungsrinont, Laura Neubert, Soeren S Huettner, Roland Kotolloshi, Katrin Schindler, Aya Ahmad, Alexander S Mosig, Lisa Adam, Alessandro Ori, Francesco Neri, Alexander Berndt, Marc-Oliver Grimm, Aria Baniahmad
• Journal: Oncogene (Oncogene) Vol. 41 Issue 23 Pg. 3263-3277 (06 2022) ISSN: 1476-5594 [Electronic] England
• PMID: 35513564 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2022. The Author(s).

Chemical References

• Androgen Receptor Antagonists
• Androgens
• Angiopoietin-2
• Hydroxybenzoates
• Receptors, Androgen
• Vascular Endothelial Growth Factor A
• atraric acid

Topics

• Androgen Receptor Antagonists (pharmacology)
• Androgens (metabolism, pharmacology)
• Angiopoietin-2 (genetics)
• Animals
• Cell Line, Tumor
• Endothelial Cells (metabolism)
• Humans
• Hydroxybenzoates
• Male
• Mice
• Prostatic Neoplasms, Castration-Resistant (drug therapy, genetics, metabolism)
• Receptors, Androgen (genetics, metabolism)
• Vascular Endothelial Growth Factor A